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to view.749 Redeﬁning Diastolic Dysfunction Grading: Combination of E/A #0.75 and
Deceleration Time >140 ms and E/e0 $10
Hiroshi Kuwaki, Masaaki Takeuchi, Victor Chien-Chia Wu, Kyoko Otani,
Yasufumi Nagata, Atsushi Hayashi, Mai Iwataki, Shota Fukuda, Hidetoshi Yoshitani,
Haruhiko Abe, Yutaka OtsujiVINI : Diastolic dysfunction (DD) is increasingly recognized. However, many patients with abnormal
diastolic function cannot be easily classiﬁed into the existing DD categories.
VIDI : In this large observational study of 1,362 patients, the incidence and prognosis of an additional
category of DD (E/A ratio #0.75, deceleration time of the mitral E-wave >140 ms, but E/e’ $10) was
reported and validated. There were 17% of patients within this new category of DD and prognosis was
similar to the pseudonormal group (and signiﬁcantly worse than the impaired relaxation group) with
respect to cardiac death and major adverse cardiac events.
VICI : The introduction of this new category allows for better diagnostic and prognostic categorization of
DD. In addition to its clinical implications, this study also demonstrates that, as imaging technology
evolves, classiﬁcation schemes should be regularly updated and revised.759 n EDITORIAL COMMENT The Heart of the Matter: Prime Time E/e0 Prime!
A. Jamil Tajik, M. Fuad Jan762 Coronary Vessel Wall Contrast Enhancement Imaging as a Potential Direct Marker of
Coronary Involvement: Integration of Findings From CAD and SLE Patients
Niharika Varma, Rocio Hinojar, David D’Cruz, Eduardo Arroyo Ucar,
Andreas Indermuehle, Sarah Peel, Gerald Greil, Nicholas Gaddum,
Phil Chowienczyk, Eike Nagel, Rene M. Botnar, Valentina O. PuntmannVINI : Coronary vessel wall enhancement (CE) by cardiac magnetic resonance is a novel noninvasive
approach to visualize coronary artery vessel wall injury and remodeling. This may have clinical implications
in vasculitis and atherosclerosis.
VIDI : In a small proof-of-principle study, the authors compared 25 coronary artery disease (CAD) patients
to 27 systemic lupus erythematosus (SLE) patients and 23 control patients and found that the pattern of
coronary CE was diffuse in SLE compared with patchy in CAD. The degree of CE was quantiﬁed using
contrast-to-noise and CE area and CE correlated with aortic stiffness, a known marker of adverse outcomes
as well as with risk factors like hypertension and hypercholesterolemia.
VICI : Although this data needs validation in larger cohorts and needs correlating with hard clinical
outcomes, coronary vessel wall CE may become a novel marker for vessel wall injury and remodeling in
high risk subjects.771 n EDITORIAL COMMENT Coronary Involvement in Lupus Patients:
Getting Sharper Pictures With Advanced Vascular Imaging?
Jie Sun, Chun YuanCONTINUED ON PAGE A-11
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AUGUST 2014 VOLUME 7, NUMBER 8774 CMR–Based Identiﬁcation of Critical Isthmus Sites of Ischemic and
Nonischemic Ventricular Tachycardia
Sebastiaan R.D. Piers, Qian Tao, Marta de Riva Silva, Hans-Marc Siebelink,
Martin J. Schalij, Rob J. van der Geest, Katja ZeppenfeldVINI : Cardiac magnetic resonance (CMR) is now increasingly becoming an important clinical tool in
directing ablation therapy for both atrial and ventricular tachyarrhythmias (VT). In VT, features of interest
are scar transmurality, which has been associated with slow conduction, and signal intensity (SI) which has
been used to identify conducting channels and to delineate core scar and border zone.
VIDI : In this study of 44 patients with prior infarction or nonischemic cardiomyopathy, CMR late gado-
linium enhancement was able to localize and characterize critical VT isthmus sites. These were typically
located in close proximity to the CMR-derived core-border zone transition and >75% transmural scar. The
area within 5 mm of both >75% transmural scar and core-border zone transition (median 13% of left
ventricular surface) contained all concealed entrainment sites and 77% of VT termination sites.
VICI : As the experience with CMR grows, characterization of arrhythmia substrates will likely continue to
improve, which is likely to increase the success rate of ablation procedures. CMR may eventually become a
standard tool in the assessment of patients prior to ablation therapy. The effect of CMR-guided ablation of
VT isthmus sites on clinical outcomes (such as recurrence of VT) warrants additional study.785 n EDITORIAL COMMENT Contrast-Enhanced CMR Imaging of Ventricular Tachycardia
Isthmus Sites to Guide Ablation: An Approach in Evolution
Srinivas R. Dukkipati, Javier Sanz788 Long-Term Outcomes of Neointimal Hyperplasia Without Neoatherosclerosis
After Drug-Eluting Stent Implantation
Jung-Sun Kim, Jung-Hee Lee, Dong-Ho Shin, Byeong-Keuk Kim, Young-Guk Ko,
Donghoon Choi, Yangsoo Jang, Myeong-Ki HongVINI : One mechanism of very late stent failure is growth of in-stent neointimal tissue which develops
features of neoatherosclerosis, which may then further progress and/or thrombose. Optical coherence
tomography (OCT) has sufﬁcient resolution to differentiate between different morphologies of in-stent
neointimal tissue. However, the clinical signiﬁcance of these characteristics remains uncertain.
VIDI : In 368 cases of mild to moderate in-stent neointimal hyperplasia after drug-eluting stents,
characterized by OCT into homogenous, heterogeneous, and layered patterns, a substantial difference in
the rate of major adverse cardiac events was demonstrated between these groups at an overall median
follow-up of 31 months.
VICI : Future studies should focus on whether routine use of invasive imaging during follow-up angiog-
raphy to identify high-risk in-stent tissue characteristics prior to clinically symptomatic disease is cost-
effective and might improve clinical outcomes.796 n EDITORIAL COMMENT Does Neointimal Characterization Following DES Implantation
Predict Long-Term Outcomes?
Kenichi Sakakura, Michael Joner, Renu VirmaniCONTINUED ON PAGE A-12
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799 Robot-Assisted Remote Echocardiographic Examination and Teleconsultation:
A Randomized Comparison of Time to Diagnosis With Standard of
Care Referral Approach
Kurt Boman, Mona Olofsson, Peter Berggren, Partho P. Sengupta, Jagat Narula804 Feasibility of Intercity and Trans-Atlantic Telerobotic Remote Ultrasound:
Assessment Facilitated by a Nondedicated Bandwidth Connection
Partho P. Sengupta, Nupoor Narula, Karen Modesto, Rami Doukky, Sarah Doherty,
Jeffery Soble, Jagat Narula810 n EDITORIAL COMMENT Remote Ultrasound: New Opportunities
Sherif F. NaguehSTATE-OF-THE-ART
PAPERS
812 Ultrafast Cardiac Ultrasound Imaging: Technical Principles, Applications,
and Clinical Beneﬁts
Maja Cikes, Ling Tong, George R. Sutherland, Jan D’hooge824 Noninvasive Imaging of Cardiovascular Injury Related to the Treatment of Cancer
Suwat Kongbundansuk, W. Gregory HundleyIMAGING VIGNETTE 839 FDG PET/CT Imaging for LVAD Associated Infections
Jongho Kim, Erika D. Feller, Wengen Chen, Vasken DilsizianCONTINUED ON PAGE A-13
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AUGUST 2014 VOLUME 7, NUMBER 8LETTERS TO THE EDITOR 843 OCT Imaging for the Management of Pulmonary Hypertension
Zhehao Dai, Yoshihiro Fukumoto, Shunsuke Tatebe, Koichiro Sugimura, Yutaka Miura,
Kotaro Nochioka, Tatsuo Aoki, Saori Miyamichi-Yamamoto, Nobuhiro Yaoita,
Kimio Satoh, Hiroaki Shimokawa845 Delayed Disruption of a Bioresorbable Vascular Scaffold
Toru Naganuma, Azeem Latib, Vasileios F. Panoulas, Katsumasa Sato,
Tadashi Miyazaki, Antonio Colombo847 Integrated 3D Echo-X-Ray Navigation to Predict Optimal Angiographic
Deployment Projections for TAVR
Michael S. Kim, John Bracken, Niels Nijhof, Ernesto E. Salcedo, Robert A. Quaife,
John C. Messenger, John D. Carroll848 Effects of Blood T1 on Extracellular Volume Calculation
Andrei Codreanu, Pauline Ferry, Marine Beaumont, Pierre-Yves Marien REPLYSteven K. White, Thomas A. Treibel, James C. MoonEDITOR’S PAGE 851 Why, When, and How Often? The Next Steps After Deﬁning the Right Tools
for Noninvasive Imaging of Cardiotoxicity
Thomas H. Marwick, Jagat NarulaIMAGING COUNCIL
CHAIRMAN’S PAGE
854 Adapting to a Changing Health Care EnvironmentPrem Soman
